Lawrence Livermore National Laboratory Licenses CDT Systems, Inc. Worldwide Manufacturing and Marketing Rights for Carbon Aerogel

Sep 21, 2006, 01:00 ET from CDT Systems, Inc.

    ADDISON, Texas, Sept. 21 /PRNewswire-FirstCall/ -- The Regents of the
 University of California, under its United States Department of Energy
 (DOE) contract to manage and operate Lawrence Livermore National Laboratory
 (LLNL) and CDT Systems, Inc. (OTC Bulletin Board:   CDTN), have executed an
 additional license under patent rights whereby CDT Systems will have rights
 to manufacture and market Carbon Aerogel worldwide, except for capacitor
 fields of use.
     This second LLNL license specifically authorizes CDT Systems to
 manufacture Carbon Aerogel for use as an electrode for the generation of
 hydrogen from water by hydrolysis and the development of proprietary
 variable pore-size Carbon Aerogel electrodes.
     CDT Systems currently has a patent license agreement with LLNL for
 Capacitive Deionization Technology for brackish water/sea water
 desalination and treatment of heat exchanger and boiler water, industrial
 and commercial process water and ultrapure industrial water.
     CDT Systems' manufacturing facility is scheduled to initially produce
 80,000 square feet of proprietary Carbon Aerogel electrodes per month.
 Current Carbon Aerogel applications include brackish water desalination,
 industrial and coalbed methane groundwater water remediation, hydrogen
 generation and Carbon Aerogel for CDT Systems' alliance partners'
     The Company is the nonexclusive business, technology licensee, and
 manufacturing associate of the U.S. Department of Energy's Lawrence
 Livermore National Laboratory ("LLNL") for the development and
 commercialization of Carbon Aerogel material sciences-based capacitive
 deionization technology (CDT) for water purification, as well as Carbon
 Aerogel for hydrogen generation, insulation, including fuel cells and
 nanotechnology electrodes.
     Statements about CDT's outlook and all other statements in this release
 other than historical facts are forward-looking statements within the
 meaning of the Private Securities Litigation Reform Act of 1995. These
 forward-looking statements rely upon a number of assumptions concerning
 future events and are subject to a number of uncertainties and other
 factors outside CDT's control, which could cause actual results to differ
 materially from such statements. While CDT believes that the assumptions
 concerning future events are reasonable, it cautions that there are
 inherent difficulties in predicting certain important factors that could
 impact the future performance. Among the important factors that could cause
 actual results to differ materially are the completion of the manufacturing
 facility and the demand for CDT's products. These and other risk factors
 are discussed in CDT's filings with the Securities and Exchange Commission,
 copies of which are available to the public. CDT expressly disclaims any
 intention or obligation to revise or update any forward-looking statements
 whether as a result of new information, future events, or otherwise.
     Contact Information: Mr. Dallas Talley, CEO, Capacitive Deionization
 Technology Systems, Inc. (CDT Systems), Addison, Texas, phone (972)
 934-1586; e-mail:

SOURCE CDT Systems, Inc.